INFANT OF DIABETIC
MOTHER
Presented by: MEHK U NISA
RN, BSN
, “OBJECTIVES….”
At the end of session the learners will be able to,
Introduce infant of diabetic mother
Define of infant of diabetic mother
Discuss pathophysiology of infant of diabetic mother
Identified risk factors of infant of diabetic mother
Describe fetal effects of maternal hyperglycemia
Explain clinical manifestations
Enlist neonatal complications of diabetes in pregnancy
Brief investgations of infant of diabetic mother
Enumerate neonatal managementb of infant of diabetic mother
, “INTRODUCTION”
•Approximately 6% of pregnancies are complicated by
maternal diabetes mellitus (80% of which are gestational).
•Maternal hyperglycaemia can result in fetal hyperglycaemia
and then secondary fetal hyperinsulinism.
•Insulin is the main 'growth hormone' of the fetus and therefore
infants of diabetic mothers (IDM) are often macrosomic (> 4,000
g) or large for gestational age (>90th percentile).
•The problems associated with being IDM relate to the effects of
hyperinsulinism and/or macrosomia
•The macrosomia is due to excessive fat deposition, visceral
organ hypertrophy (except brain and kidney) and acceleration of
body mass accretion.
•Macrosomic IDMs have higher rates of neonatal morbidity and
mortality.
MOTHER
Presented by: MEHK U NISA
RN, BSN
, “OBJECTIVES….”
At the end of session the learners will be able to,
Introduce infant of diabetic mother
Define of infant of diabetic mother
Discuss pathophysiology of infant of diabetic mother
Identified risk factors of infant of diabetic mother
Describe fetal effects of maternal hyperglycemia
Explain clinical manifestations
Enlist neonatal complications of diabetes in pregnancy
Brief investgations of infant of diabetic mother
Enumerate neonatal managementb of infant of diabetic mother
, “INTRODUCTION”
•Approximately 6% of pregnancies are complicated by
maternal diabetes mellitus (80% of which are gestational).
•Maternal hyperglycaemia can result in fetal hyperglycaemia
and then secondary fetal hyperinsulinism.
•Insulin is the main 'growth hormone' of the fetus and therefore
infants of diabetic mothers (IDM) are often macrosomic (> 4,000
g) or large for gestational age (>90th percentile).
•The problems associated with being IDM relate to the effects of
hyperinsulinism and/or macrosomia
•The macrosomia is due to excessive fat deposition, visceral
organ hypertrophy (except brain and kidney) and acceleration of
body mass accretion.
•Macrosomic IDMs have higher rates of neonatal morbidity and
mortality.